Your browser doesn't support javascript.
loading
Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster.
Shoji, Naoko; Tanese, Keiji; Sasaki, Ayano; Horiuchi, Taishi; Utsuno, Yuji; Fukuda, Koichi; Hoshino, Yukiko; Noda, Shinichi; Minami, Hirofumi; Asakura, Wataru.
Afiliación
  • Shoji N; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Tanese K; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Sasaki A; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Horiuchi T; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Utsuno Y; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Fukuda K; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Hoshino Y; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Noda S; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Minami H; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
  • Asakura W; Office of New Drug IV, Pharmaceuticals and Medical Device Agency, Tokyo, Japan.
J Dermatol ; 47(7): 683-688, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32424854

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Herpes Zóster Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Herpes Zóster Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Japón